retatrutide clinical trial malaysia A study of Lilly's weight loss drug in people with heart disease did not answer a crucial question — whether it reduces cardiovascular risk Retatrutide shows significant weight loss

In a pre-specified extension cohort restricted to participants with a BMI of at least 35, average weight loss reached 30.3% at 104 weeks

Those few minutes of stillness might be the calmest part of your day

JMIR Aging

The PlexusDx intake process asks you to choose a GLP-1 preference before submission

Although a direct comparison of high-dose oral allulose with injectable GLP-1 drugs remains to be done, the preliminary data suggests that adding allulose to your diet (or better yet including it in food products that are easily integrated into any diet) may provide a more natural alternative to achieving long-term weight loss than to use of chemically modified hormones (i.e., GLP-1 drugs) with their significant side effects

Many participants report feeling intoxicated more quickly with less alcohol than before